暗扩散征:血管内治疗卒中患者出血转化的新型MRI预测指标?
基于FRAME研究127例大血管闭塞急性缺血性卒中并接受血管内治疗的患者,评估治疗前MRI暗扩散征与再灌注后24小时豆状核出血转化及3个月功能结局的关系。暗扩散征阳性57例(44.9%),与豆状核出血转化独立相关(OR 4.52;95% CI 1.89-11.37;P=.0009),但与3个月功能结局无关。
要点
- 治疗前MRI暗扩散征阳性者再灌注后24小时豆状核出血转化风险独立升高(OR 4.52)。
- 暗扩散征与3个月功能结局无关,仅基线NIHSS严重程度是其唯一决定因素。
- 暗扩散征定义为基线DWI上豆状核区透镜状不均匀信号,需在术前MRI中识别。
核心结论
- 治疗前MRI上的暗扩散征可能是血管内治疗后出血转化的独立预测指标,但与功能结局无关。
- 暗扩散征的病理生理机制仍有待研究。
- 鉴于样本量小及人群特征,结果需进一步研究证实。
研究设计与样本
- 研究类型为FRAME研究(法国急性多模态影像选择机械取栓患者研究)的参与者分析。
- 纳入127例大血管闭塞急性缺血性卒中并接受血管内治疗的患者,平均年龄70岁,女性占47%。
- 评估治疗前MRI暗扩散征与再灌注后24小时豆状核出血转化及3个月功能结局的关联,采用单变量和多变量分析。
- 参考标准为再灌注后24小时影像上的豆状核出血转化。
关键影像表现/征象
- 暗扩散征表现为基线扩散加权成像上豆状核区透镜状不均匀信号。
- 57例(44.9%)基线MRI存在暗扩散征,55例(43.3%)治疗后影像出现豆状核出血转化。
- 发生治疗后豆状核出血转化的患者中36例(65.5%)暗扩散征阳性,无出血转化者中21例(29.2%)阳性(P=.0001)。
诊断标准与关键数值
- 暗扩散征阳性定义为治疗前扩散加权成像上豆状核区出现透镜状不均匀信号。
- 多变量分析中暗扩散征与24小时豆状核出血转化独立相关(OR 4.52;95% CI 1.89-11.37;P=.0009)。
- 暗扩散征与3个月功能结局无独立关联。
- 基线NIHSS严重程度是暗扩散征的唯一决定因素。
临床应用与阅片要点
- 阅片时注意治疗前DWI上豆状核区是否存在透镜状不均匀信号(暗扩散征),阳性者提示再灌注后24小时豆状核出血转化风险升高。
- 暗扩散征与3个月功能结局无关,报告时可提示其预测出血转化但不预测功能结局。
- 原文未据此给出推荐。
局限性
- 样本量小。
- 人群特征限制结果外推。
- 结果需进一步研究证实。
- 暗扩散征的病理生理机制仍有待研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Intracerebral hemorrhagic transformation (HT) is associated with poor outcome after reperfusion therapies in patients with stroke but is difficult to anticipate. Some patients with acute ischemic stroke (AIS) due to large vessel occlusion (LVO) can exhibit a lenticular heterogeneous signal on their baseline diffusion-weighted imaging that we called the dark diffusion sign (DDS). Our aim was to evaluate whether the presence of the DDS on pretreatment MRI of patients with LVO-AIS is associated with increased risk of HT after endovascular therapy (EVT).
MATERIALS AND METHODS: Participants from the French Acute Multimodal Imaging Study to Select Patients for Mechanical Thrombectomy (FRAME) who had LVO-AIS treated with EVT were included. Association of DDS on pretreatment MRI with posttreatment lenticular nucleus hemorrhagic transformation (LNHT) 24 hours postreperfusion as well as the association with the 3-month functional outcome were evaluated by using univariable and multivariable analyses. The same statistical methods were used to evaluate the determinants of the DDS.
RESULTS: One hundred twenty-seven patients were included (mean age 70 years old, 47% women). DDS was present in the baseline MRI of 57 patients (44.9%) and 55 (43.3%) had lenticular hemorrhagic transformation on posttreatment imaging. DDS was present in 36 patients (65.5%) who experienced posttreatment LNHT compared with 21 (29.2%) in those without HT (P = .0001). In multivariable analysis, DDS was independently associated with HT in LN at 24 hours (OR: 4.52; 95% CI, 1.89-11.37; P = .0009) but not with the 3-month functional outcome. NIHSS severity at baseline was the only determinant of the DDS.
CONCLUSIONS: DDS on pretreatment imaging could be an independent predictor of HT but was not associated with the functional outcome. Pathophysiologic mechanisms underlying DDS remain to be investigated. The results must be confirmed by further studies, given the small sample size and the population characteristics.
引用
- Lyon V, Raposo N, Bonneville F, et al. Dark Diffusion Sign: A Novel MRI Predictor of Hemorrhagic Transformation in Patients with Stroke Treated with Endovascular Therapy? AJNR Am J Neuroradiol. 2025. PMID: 41344847. doi:10.3174/ajnr.A8920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。